Valantine Hannah Insider Trading Activity
Valantine Hannah has been net-selling over the last 12 months with 0 purchases and 10 sales across 2 different companies.
BBIO is the most-traded position with 9 trades. The largest single transaction was a sale of BBIO for $1.7M on Nov 12, 2025.
Performance Scorecard
Forward stock performance after each transaction by Valantine Hannah. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -2.2% | 10% | 10 |
| 90 days | — | -7.6% | 20% | 10 |
| 120 days | — | -16.0% | 14% | 7 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Valantine Hannah bought and sold BBIO.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | BBIO | Sell | 8,671 | $72.00 | $624K | Director |
| Feb 27, 2026 | BBIO | Sell | 14,584 | $67.08 | $978K | Director |
| Feb 27, 2026 | BBIO | Sell | 10,900 | $67.84 | $739K | Director |
| Nov 12, 2025 | BBIO | Sell | 25,484 | $66.07 | $1.7M | Director |
| Jun 26, 2025 | BBIO | Sell | 876 | $44.11 | $39K | Director |
| Jun 26, 2025 | BBIO | Sell | 1,542 | $44.01 | $68K | Director |
| Jun 26, 2025 | BBIO | Sell | 398 | $44.13 | $18K | Director |
| Jun 26, 2025 | BBIO | Sell | 1,891 | $44.03 | $83K | Director |
| Jun 18, 2025 | CDNA | Sell | 10,570 | $19.16 | $203K | Director |
| Jun 10, 2025 | BBIO | Sell | 4,292 | $40.00 | $172K | Director |
Top Companies Traded
Other insiders at BridgeBio Pharma, Inc.
7 other tracked filers at BBIO.